Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Fibrosis, a pathologic process in which progressive scarring replaces functional tissue, drives the progression of several debilitating diseases. Uncontrolled, progressive fibrosis leads to organ dysfunction and failure, and potentially death. In the U.S., many millions of Americans are afflicted with a fibrosis-related disease, which may affect organs including the kidney, liver, lungs, skin, and eye. Blade has assembled scientific and leadership teams with unparalleled experience. Our scientific team as well as our Board have extensive expertise in fibrosis and the discovery and development of anti-fibrotic drugs. Blade’s scientific advisory board includes world renowned experts in the pathobiology of fibrotic disease. By targeting novel pathways common to multiple fibrotic disease states, we believe we can build the leading company in anti-fibrotic drug discovery and development.
View Top Employees from Blade TherapeuticsWebsite | http://www.blademed.com |
Revenue | $20 million |
Funding | $51.5 million |
Employees | 26 (15 on RocketReach) |
Founded | 2015 |
Address | 50 Francisco St Suite 450, San Francisco, California 94133, US |
Phone | (650) 278-4291 |
Technologies |
JavaScript,
HTML,
Google Analytics
+5 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Business Services General, Biopharma, Pharmaceutical drug development, Business Services, Fibrotic disease, Research, Health Care, Science and Engineering, Pharmaceutical, Therapeutics |
Web Rank | 6 Million |
Keywords | Blade Therapeutics, Blade Therapeutics Pipeline |
Competitors | Encycle Therapeutics Inc, Galectin Therapeutics, Sequella, Inc., Therapeutic Frontiers Ltd, iBio, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Blade Therapeutics employee's phone or email?
The Blade Therapeutics annual revenue was $20 million in 2024.
Walter Yu is the Director of Blade Therapeutics.
15 people are employed at Blade Therapeutics.
Blade Therapeutics is based in San Francisco, California.
The NAICS codes for Blade Therapeutics are [5417, 54, 54171, 541714, 541].
The SIC codes for Blade Therapeutics are [873, 87].